Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterNo recent work listed

Hany Elsaleh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2083-4961; OpenAlex author ID A5015405711. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper

Papers 2

  1. Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway Approach. Last author DOI 10.1097/mpa.0000000000000710↗
  2. Cytidine deaminase single-nucleotide polymorphism is predictive of toxicity from gemcitabine in patients with pancreatic cancer: RTOG 9704. Last author DOI 10.1038/tpj.2011.22↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chandan Guha · 2 shared papers, 2012–2016 · strength 0.09
  2. William F. Regine · 1 shared paper, 2016 · strength 0.05
  3. John S. Macdonald · 1 shared paper, 2016 · strength 0.05
  4. Xiyong Liu · 1 shared paper, 2016 · strength 0.05
  5. Yun Yen · 1 shared paper, 2016 · strength 0.05
  6. James J. Farrell · 1 shared paper, 2016 · strength 0.05
  7. Al B. Benson · 1 shared paper, 2016 · strength 0.05
  8. J J Farrell · 1 shared paper, 2012 · strength 0.04
  9. Adam Paul Dicker · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.